Questions and answers for biological medicinal products
Questions and answers for biological medicinal products
Questions and answers for biological medicinal products
Human medicines European public assessment report (EPAR): Intrarosa, prasterone, Date of authorisation: 08/01/2018, Revision: 8, Status: Authorised
Paediatric Committee (PDCO): 19-22 May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 May 2026 to 22 May 2026
Committee for Medicinal Products for Human Use (CHMP): 20-23 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 20 July 2026 to 23 July 2026
Herbal medicinal product: Liquiritiae radix, Glycyrrhiza glabra L.; Glycyrrhiza inflata Bat.; Glycyrrhiza uralensis Fisch., D: Draft under discussion
Cancer Medicines Forum: June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, 23 June 2026
Signal assessment report on neurodevelopmental disorders with paternal exposure to valproate and related substances
Advice on the influenza virus on request from the Medical Device Coordination Group
Veterinary pharmacovigilance cluster - Terms of reference
Veterinary medicinal products cluster - Terms of reference